In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $254.48 in the prior trading day, West Pharmaceutical Services, Inc (NYSE: WST) closed at $261.52, up 2.77%. In other words, the price has increased by $2.77 from its previous closing price. On the day, 0.59 million shares were traded. WST stock price reached its highest trading level at $262.895 during the session, while it also had its lowest trading level at $255.225.
Ratios:
Our goal is to gain a better understanding of WST by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 36.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.67. For the most recent quarter (mrq), Quick Ratio is recorded 2.08 and its Current Ratio is at 2.78. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Rothschild & Co Redburn on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $311.
On June 24, 2025, Barclays started tracking the stock assigning a Equal Weight rating and target price of $245.
On March 18, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $275.Evercore ISI initiated its Outperform rating on March 18, 2025, with a $275 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 29 ’24 when Witherspoon Charles sold 703 shares for $310.40 per share. The transaction valued at 218,211 led to the insider holds 1,253 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WST now has a Market Capitalization of 18805202944 and an Enterprise Value of 18603704320. As of this moment, West’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.17, and their Forward P/E ratio for the next fiscal year is 34.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.35 while its Price-to-Book (P/B) ratio in mrq is 6.42. Its current Enterprise Value per Revenue stands at 6.285 whereas that against EBITDA is 23.564.
Stock Price History:
The Beta on a monthly basis for WST is 1.06, which has changed by -0.12873137 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, WST has reached a high of $352.33, while it has fallen to a 52-week low of $187.43. The 50-Day Moving Average of the stock is 5.88%, while the 200-Day Moving Average is calculated to be 4.45%.
Shares Statistics:
The stock has traded on average 697.94K shares per day over the past 3-months and 685220 shares per day over the last 10 days, according to various share statistics. A total of 71.90M shares are outstanding, with a floating share count of 71.46M. Insiders hold about 0.62% of the company’s shares, while institutions hold 98.19% stake in the company. Shares short for WST as of 1757894400 were 1678327 with a Short Ratio of 2.40, compared to 1755216000 on 1793550. Therefore, it implies a Short% of Shares Outstanding of 1678327 and a Short% of Float of 3.0700000000000003.
Dividends & Splits
In the trailing 12 months, WST’s forward annual dividend rate was 0.83, compared to 0.84 this year. Against a Trailing Annual Dividend Yield of 0.003261553. The stock’s 5-year Average Dividend Yield is 0.24. . The current Payout Ratio is 12.27% for WST, which recently paid a dividend on 2025-07-30 with an ex-dividend date of 2025-11-12. Stock splits for the company last occurred on 2013-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 11.0 different market analysts. The consensus estimate for the next quarter is $1.78, with high estimates of $1.83 and low estimates of $1.71.
Analysts are recommending an EPS of between $6.97 and $6.65 for the fiscal current year, implying an average EPS of $6.78. EPS for the following year is $7.6, with 14.0 analysts recommending between $8.21 and $7.34.
Revenue Estimates
10 analysts predict $788.41M in revenue for . The current quarter. It ranges from a high estimate of $791.9M to a low estimate of $785M. As of . The current estimate, West Pharmaceutical Services, Inc’s year-ago sales were $746.9MFor the next quarter, 10 analysts are estimating revenue of $796.36M. There is a high estimate of $804.6M for the next quarter, whereas the lowest estimate is $787.15M.
A total of 13 analysts have provided revenue estimates for WST’s current fiscal year. The highest revenue estimate was $3.06B, while the lowest revenue estimate was $3.04B, resulting in an average revenue estimate of $3.05B. In the same quarter a year ago, actual revenue was $2.89BBased on 13 analysts’ estimates, the company’s revenue will be $3.24B in the next fiscal year. The high estimate is $3.28B and the low estimate is $3.19B.
